Mr Davy Vanden Broeck

Visiting Professor


Davy Vanden Broeck holds a M.Sc. degree in Biochemistry from the University of Antwerp. In 2007, he also obtained a PhD from the University of Antwerp in the field of molecular biology at the Faculty of Biomedical Sciences. Currently, Dr. Vanden Broeck is senior researcher at the ICRH Belgium, lecturer at the University of Nairobi and associated post-doctoral researcher at the University of Antwerp. Furthermore, he has been involved in reproductive health research for over 5 years, both in Belgium and in Kenya. Dr. Vanden Broeck was member of the Senior Management of ICRH Kenya and was laboratory manager in ICRH Mombasa (Kenya).

His research focuses on human papilloma virus (HPV) and related cervical cancer. In this capacity, he has been involved in various projects and he has been the supervisor of PhD/MSc dissertations and responsible for a number of projects in the same field.

Publications of Davy

2021 Cervical cancer screening using HPV tests on self-samples : attitudes and preferences of women participating in the VALHUDES study

2021 Clinical and analytical evaluation of the RealTime High Risk HPV assay in Colli-Pee collected first-void urine using the VALHUDES protocol

2021 Development and validation of a wart-associated human papilloma virus genotyping assay for detection of HPV in cutaneous warts

2020 Efficacy of AV2-Salicylic acid combination therapy for cutaneous warts : study protocol for a single-center randomized controlled trial

2019 Type-specific human papillomavirus prevalence, incident cases, persistence, and associated pregnancy outcomes among HIV-infected women in Kenya

Stanley Luchters

2019 Performance of OncoE6 (TM) Cervical Test in detecting cervical precancer lesions in HIV-positive women attending an HIV clinic in Bujumbura, Burundi : a cross-sectional study

2019 Prevalence and genotype-specific distribution of human papillomavirus in Burundi according to HIV status and urban or rural residence and its implications for control

2019 Using the VALGENT-3 framework to assess the clinical and analytical performance of the RIATOL qPCR HPV genotyping assay

2018 Knowledge and practices of general practitioners at district hospitals towards cervical cancer prevention in Burundi, 2015 : a cross-sectional study

Heleen Vermandere

2018 Uptake of three doses of HPV vaccine by primary school girls in Eldoret, Kenya : a prospective cohort study in a malaria endemic setting

Heleen Vermandere

2018 Human papilloma virus infection in HIV-infected women in Belgium : implications for prophylactic vaccines within this subpopulation

2018 Time has come to include Human Papillomavirus (HPV) testing in sperm donor banks

2018 VALHUDES : a protocol for validation of human papillomavirus assays and collection devices for HPV testing on self-samples and urine samples

2018 Validation of intra- and inter-laboratory reproducibility of the Xpert HPV assay according to the international guidelines for cervical cancer screening

2017 Multiple HPV infections in female sex workers in Western Kenya : implications for prophylactic vaccines within this sub population

Emilomo Ogbe

2017 Factors associated with HIV testing among men who have sex with men in Western Kenya : a cross-sectional study

Heleen Vermandere

2017 A high resolution melting (HRM) technology-based assay for cost-efficient clinical detection and genotyping of herpes simplex virus (HSV)-1 and HSV-2

2017 Associations between highly active antiretroviral therapy and the presence of HPV, premalignant and malignant cervical lesions in sub-Saharan Africa, a systematic review : current evidence and directions for future research

2016 Associations between vaginal infections and potential high-risk and high-risk human papillomavirus genotypes in female sex workers in Western Kenya

Emilomo Ogbe

2016 Epidemiology of HPV genotypes among HIV positive women in Kenya : a systematic review and meta-analysis

Stanley Luchters